¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximow stain for bone marrow"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • lacrimal bone
    ´«¹°»À, ´©°ñ
  • long bone
    ±ä»À, Àå°ñ
  • malar bone
    ±¤´ë»À, °ü°ñ
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
  • maxillary bone
    À§ÅλÀ, »ó¾Ç°ñ
  • membrane bone
    ¸·»À, ¸·»ó°ñ
  • membranous bone graft
    ¸·»ÀÀ̽Ä, ¸·¼º°ñÀ̽Ä
  • metacarpal bone
    ¼ÕÇ㸮»À, Áß¼ö°ñ
  • metaplastic bone
    È­»ý»À
  • metatarsal bone
    ¹ßÇ㸮»À, ÁßÁ·°ñ
  • navicular bone
    ¹ß¹è»À, ÁÖ»ó°ñ
  • nasal bone
    ÄÚ»À, ºñ°ñ
  • nasal bone fracture
    ÄÚ»À°ñÀý
  • nonlamellated bone
    ¹«Ãþ»À
  • nonvascularized bone graft
    ºñÇ÷°ü»ÀÀ̽Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • malar bone
    (¢¡zygomatic bone) ±¤´ë»À
  • maxillary bone
    (¢¡maxilla) À§ÅλÀ, »ó¾Ç°ñ
  • membrane bone
    ¸·»À
  • metacarpal bone
    ¼ÕÇ㸮»À
  • metaplastic bone
    È­»ý»À
  • metatarsal bone
    ¹ßÇ㸮»À
  • nasal bone
    ÄÚ»À
  • navicular bone
    ¹ß¹è»À
  • nonlamellated bone
    (¢¡woven bone) ¹«Ãþ»À
  • occipital bone
    µÚÅë¼ö»À
  • palatine bone
    ÀÔõÀå»À
  • parietal bone
    ¸¶·ç»À
  • pisiform bone
    Äá¾Ë»À
  • pneumatic bone
    °ø±â»À
  • premaxillary bone
    (¢¡premaxilla) ¾ÕÀ§ÅλÀ, »ó¾ÇÀü±¸°ñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • marrow cell
    °ñ¼ö¼¼Æ÷(¡­á¬øà).
  • marrow derived cell
    °ñ¼öÀ¯·¡¼¼Æ÷(?ËôËÄËṴ̂).
  • marrow derived cell
    °ñ¼öÀ¯·¡¼¼Æ÷(¡­ë¦ÕÎá¬øà).
  • marrow examination
    °ñ¼ö°Ë»ç
  • marrow infiltration
    °ñ¼öħÀ±
  • marrow sideroblast
    °ñ¼öö¸ð±¸(?̧ËÎË´).
  • marrow sideroblast
    °ñ¼öö¸ð±¸(¡­ôÑٽϹ).
  • marrow space
    °ñ¼ö°­(ÍéâÐË·).
  • marrow transplantation
    °ñ¼öÀ̽Ä
  • normoblastic marrow
    Á¤Àû¾Æ±¸¼º(ïáîåٽϹàõ) °ñ¼ö
  • red marrow
    Àû»ö°ñ¼ö, Àû°ñ¼ö(îåÍéâÐ).
  • red marrow
    Àû»ö°ñ¼ö (Àû»ö»À¼ÓÁú)
  • secondary marrow space
    ÀÌÂ÷°ñ¼ö°£°Ý(ì£ó­ÍéâÐÊà̰).
  • spinal marrow
    ô¼ö(ô±âÐ).
  • sternal marrow
    Èä°ñ°ñ¼ö.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
MIT Massachusetts Institute of Technology; male impotence test; marrow iron turnover; melodic intonation...
MMNC marrow mononuclear cell
MNR marrow neutrophil reserve
MPR mannose 6-phosphate receptor; marrow production rate; massive preretinal retraction; maximum pulse r...
MRA magnetic resonance angiography; main renal artery; marrow repopulation activity; medical record anal...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
N-BM normal bone marrow
BMT post-bone marrow transplantation
BPTB Bone-patellar tendon-bone
EBMT European Group for Blood and Marrow Transplantation
LTMC Long-term marrow culture
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lamellar endochondral bone
    ÃþÆÇ ¿¬°ñ¼Ó »À
  • lamellar membranous bone
    ÃþÆÇ ¸·
  • latent bone cavity
    Àẹ¼º °ñ ³¶
  • lateral cuneiform bone
    °¡ÂÊ ½û±â »À
  • lesser multangular bone
    ¼Ò ´Ù°¢ °ñ, ¼Ò ´ÉÇü °ñ
  • long bone
    ±ä »À, Àå°ñ
    »çÁö¿¡¼­ º¸´Â »À·Î¼­ ´ëÅð°ñ, ºñ°ñ, °æ°ñ µîÀÌ ÀÖ´Ù.
  • marble bone disease
    °ñ È­¼®Áõ, ´ë¸®¼® °ñº´
    ´ß ¹éÇ÷º´ À°Á¾±º¿¡ ¼ÓÇÏ´Â º´. °ñÇü ¸²ÇÁÁ¾À̶ó°íµµ ÇÏ´Â ÀÌ º´Àº, »À°¡ ±½¾îÁö´Â °ÍÀÌ Æ¯Â¡À̸ç, ¹ß»ýÀÌ µå¹°±â ¶§¹®¿¡ °æÁ¦ÀûÀ¸·Î Å« ¶æÀº ¾ø´Ù. Ç÷±¸¿Í ÀüÇô °ü°è¾øÀÌ »À ¼¼Æ÷°¡ Áõ½ÄÇϹǷΠÇ÷±¸¿¡¼­ À¯·¡ÇÏ´Â Á¾¾çÀÌ ¾Æ´Ï¶ó, ¹éÇ÷º´°ú °°Àº ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ÀϾ´Â º´À̱⠶§¹®¿¡ ¹éÇ÷º´À¸·Î Ãë±ÞµÈ´Ù.
  • mastoid bone
    À¯¾ç °ñ
  • maxillary bone
    »ó¾Ç°ñ
  • medullary bone
    ¼öÁú°ñ
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metastatic bone tumor
    ÀüÀ̼º °ñ Á¾¾ç
  • nasal bone
    ºñ°ñ
    ÄàµîÀ» Çü¼ºÇÏ´Â µÎ °³ÀÇ À广Çü »À Áß Çϳª.
  • nasal process of the frontal bone
    ÀüµÎ°ñ ºñºÎ
  • nonlamellar bone
    ºñÃþÆÇ°ñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
Roux's stain <technique> A double stain for diphtheria bacilli which employs crystal violet or dahlia and methyl green.
(05 Mar 2000)
Ciaccio's stain <technique> A method for demonstrating complex insoluble intra-cellular lipids using fixation in a formalin-dichromate solution, embedding in paraffin, staining with Sudan III or IV, and examination in aqueous mountant.
(05 Mar 2000)
phosphotungstic acid stain <technique> The first general stain used for electron microscopy; a selective stain for extracellular components such as elastin, collagen, and basement membrane mucopolysaccharides; it can be followed by uranyl acetate or lead.
Synonym: PTA stain.
(05 Mar 2000)
Wachstein-Meissel stain <technique> For calcium-magnesium-ATPase, a method similar to that of Gomori's non-specific acid phosphatase stain, except that incubation is carried out with ATP as substrate at neutral pH; enzyme activity is generally demonstrated at cell membranes.
(05 Mar 2000)
Warthin-Starry silver stain <technique> A stain for spirochetes in which preparations are incubated in 1% silver nitrate solution followed by a developer.
(05 Mar 2000)
picrocarmine stain <technique> A red crystalline powder derived from a solution of carmine, ammonia, and picric acid which is evaporated, leaving the powder (soluble in water); it produces excellent staining of keratohyaline granules.
(05 Mar 2000)
picro-Mallory trichrome stain <technique> A modification of Mallory's trichrome stain that involves the addition of picric acid.
(05 Mar 2000)
picronigrosin stain <technique> A solution of nigrosin in picric acid, used for staining connective tissue.
(05 Mar 2000)
Weigert-Gram stain <technique> A stain for bacteria in tissues in which sections are stained in alum-haematoxylin, then in eosin, aniline methyl violet, and Lugol's solution.
(05 Mar 2000)
Weigert's iron haematoxylin stain <technique> A nuclear staining solution containing haematoxylin, ferric chloride, and hydrochloric acid; useful in combination with von Gieson's stain, especially for demonstrating connective tissue elements or Entamoeba histolytica in sections.
(05 Mar 2000)
Weigert's stain <technique> 1. For actinomyces, a staining method using immersion in a dark red orsellin solution in alcohol, then staining in crystal-violet solution.
See: iron haematoxylin.
2. For elastin, a staining solution of fuchsin, resorcin, and ferric chloride; elastic fibres stain blue-black.
3. For fibrin, a staining method using solutions of aniline-crystal violet and iodine-potassium iodide, then decolorizing in aniline oil and xylol; the fibrin is stained dark blue.
4. For myelin, a staining method using ferric chloride and haematoxylin; myelin stains deep blue, degenerated portions a light yellowish colour.
5. For neuroglia, a complicated process in which the final treatment is like that for staining fibrin; neuroglia and nuclei stain blue.
6. For reticulum, a silver impregnation technique in which reticulum appears as black, well-defined fibres without beading and with a relatively clear background.
(05 Mar 2000)
Mowry's colloidal iron stain <technique> A stain used for demonstrating acid mucopolysaccharides.
(05 Mar 2000)
Williams' stain <technique> A stain for Negri bodies which utilises picric acid, fuchsin, and methylene blue; Negri bodies are magenta, granules and nerve cells blue, and erythrocytes yellowish.
(05 Mar 2000)
plasma stain <technique> Plasmatic stainplasmic stain, a stain whose principal affinity is for the cytoplasm of cells.
(05 Mar 2000)
MSB trichrome stain <technique> A stain for fibrin using martius yellow, brilliant crystal scarlet 6R, and soluble blue; fibrin is selectively stained red and connective tissue appears blue.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á